1.WHO: Global Tuberculosis Report 2017: Geneva: World Health Organization; 2017.
2.Lambert M-L, Hasker E, Deun AV, Roberfroid D, Boelaert M, Van der Stuyft P: Recurrence in tuberculosis: relapse or reinfection? The Lancet Infectious Diseases 2003, 3(5):282–287.
3.Niemann S, Koser CU, Gagneux S, Plinke C, Homolka S, Bignell H, Carter RJ, Cheetham RK, Cox A, Gormley NA et al: Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLoS One 2009, 4(10):e7407.
4.Bryant JM, Harris SR, Parkhill J, Dawson R, Diacon AH, van Helden P, Pym A, Mahayiddin AA, Chuchottaworn C, Sanne IM et al: Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med 2013, 1(10):786–792.
5.Hatherell HA, Colijn C, Stagg HR, Jackson C, Winter JR, Abubakar I: Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review. BMC Med 2016, 14:21.
6.EuroTB (InVS/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region: Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2000. Saint-Maurice, France: Institut de Veille Sanitaire; 2003.
7.European Centre for Disease Prevention and Control/WHO Regional Office for Europe: Tuberculosis surveillance and monitoring in Europe 2018—2016 data. Stockholm: European Centre for Disease Prevention and Control; 2018.
8.Jenkins HE, Ciobanu A, Plesca V, Crudu V, Galusca I, Soltan V, Cohen T: Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova. Int J Tuberc Lung Dis 2013, 17(3):373–380.
9.Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M et al: Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J 2013, 42(5):1291–1301.
10.Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, Van den Bergh R, Kumar AM, de Colombani P: Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action 2014, 4(Suppl 2):S59–63.
11.Crudu V, Merker M, Lange C, Noroc E, Romancenco E, Chesov D, Gunther G, Niemann S: Nosocomial transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2015, 19(12):1520–1523.
12.Rosenthal A, Gabrielian A, Engle E, Hurt DE, Alexandru S, Crudu V, Sergueev E, Kirichenko V, Lapitskii V, Snezhko E et al: The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis. J Clin Microbiol 2017, 55(11):3267–3282.
13.Garrigo M, Aragon LM, Alcaide F, Borrell S, Cardenosa E, Galan JJ, Gonzalez-Martin J, Martin-Casabona N, Moreno C, Salvado M et al: Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2007, 45(6):1766–1770.
14.Wilson K: Preparation of genomic DNA from bacteria. Curr Protoc Mol Biol 2001, Chapter 2:Unit 2 4.
15.Li H, Durbin R: Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010, 26(5):589–595.
16.Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, Cuomo CA, Zeng Q, Wortman J, Young SK et al: Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One 2014, 9(11):e112963.
17.Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso–2; iso–3. Fly (Austin) 2012, 6(2):80–92.
18.Coll F, McNerney R, Preston MD, Guerra-Assuncao JA, Warry A, Hill-Cawthorne G, Mallard K, Nair M, Miranda A, Alves A et al: Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med 2015, 7(1):51.
19.Coll F, McNerney R, Guerra-Assuncao JA, Glynn JR, Perdigao J, Viveiros M, Portugal I, Pain A, Martin N, Clark TG: A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun 2014, 5:4812.
20.Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L et al: Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLoS Med 2015, 12(9):e1001880.
21.ReSeqTB Program [https://platform.reseqtb.org/]
22.Wilm A, Aw PP, Bertrand D, Yeo GH, Ong SH, Wong CH, Khor CC, Petric R, Hibberd ML, Nagarajan N: LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 2012, 40(22):11189–11201.
23.Fishbein S, van Wyk N, Warren RM, Sampson SL: Phylogeny to function: PE/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity. Mol Microbiol 2015, 96(5):901–916.
24.Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4(4):406–425.
25.Kumar S, Stecher G, Tamura K: MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol 2016, 33(7):1870–1874.
26.Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19(12):1572–1574.
27.Clement M, Posada D, Crandall KA: TCS: a computer program to estimate gene genealogies. Mol Ecol 2000, 9(10):1657–1659.
28.Stimson J, Gardy J, Mathema B, Crudu V, Cohen T, Colijn C: Beyond the SNP Threshold: Identifying Outbreak Clusters Using Inferred Transmissions. Mol Biol Evol 2019, 36(3):587–603.
29.Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsaker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F: Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient. Genome Biol 2014, 15(11):490.
30.Wollenberg KR, Desjardins CA, Zalutskaya A, Slodovnikova V, Oler AJ, Quinones M, Abeel T, Chapman SB, Tartakovsky M, Gabrielian A et al: Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus. J Clin Microbiol 2017, 55(2):457–469.
31.Casali N, Nikolayevskyy V, Balabanova Y, Harris SR, Ignatyeva O, Kontsevaya I, Corander J, Bryant J, Parkhill J, Nejentsev S et al: Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 2014, 46(3):279–286.
32.Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, Eyre DW, Wilson DJ, Hawkey PM, Crook DW et al: Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013, 13(2):137–146.
33.Roetzer A, Diel R, Kohl TA, Ruckert C, Nubel U, Blom J, Wirth T, Jaenicke S, Schuback S, Rusch-Gerdes S et al: Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 2013, 10(2):e1001387.
34.Maus CE, Plikaytis BB, Shinnick TM: Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005, 49(2):571–577.
35.Zaunbrecher MA, Sikes RD, Jr., Metchock B, Shinnick TM, Posey JE: Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2009, 106(47):20004–20009.